Ceribell, Inc.

CBLL

Held by 1 specialist biotech fund

Share on X

Fund Holdings

Redmile Group

AI Signal

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Redmile GroupNEWFeb 17, 2026

Shares: 435,239Value: $9.5M

# Signal Note: Redmile Initiates Ceribell Position Redmile's $9.5M entry into CBLL (435K shares) signals conviction in Ceribell's EEG-based seizure detection platform, which addresses an underserved diagnostic gap in epilepsy monitoring. The timing likely reflects confidence in near-term revenue inflection from hospital adoption and potential reimbursement tailwinds, though the company remains pre-profitability with execution risk around sustained market penetration.

More CBLL Analysis

Insider buy/sell details with names, titles, and amounts
AI-generated context for every signal

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

ATRA1 fund IMNM1 fund KRYS1 fund ADCT1 fund KLRS1 fund CLDX1 fund NGNE1 fund COGT

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: